Our Services
Discovera S.r.l. provides integrated computational drug discovery services designed to support pharmaceutical and biotech research programs from early concept to lead optimization. The company offers advanced in-silico solutions that enhance target evaluation, compound design, and candidate selection, helping partners accelerate development timelines and improve decision-making through data-driven methodologies.
Drug Repurposing
Discovera computationally screens approved and clinical-stage compounds against your disease target using AI-driven virtual screening, molecular dynamics, and polypharmacology analysis.
Identify repurposing candidates with predicted binding affinity, selectivity profiles, and safety flags.
SB-CADD
Discovera provides structure-based CADD consulting to resolve mechanistic uncertainty before experimental commitment. Compounds and targets are evaluated through rigorous structural modeling and comparative interaction analysis, translating findings into clear conclusions.​
Variants Analysis
Our population-specific analysis framework integrates structural bioinformatics, biophysical simulations, and genetics to predict how genetic variants reshape protein structure, dynamics, and drug-target interactions across human populations. Our approach provides the mechanistic foundation for anticipating inter-individual variability in drug efficacy and safety.
Get a Quote
Send an email at info@discoverapharma.com